Dermapharm Holding 将来の成長
Future 基準チェック /16
Dermapharm Holding利益と収益がそれぞれ年間18.1%と4.1%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に18.6% 18.1%なると予測されています。
主要情報
18.1%
収益成長率
18.1%
EPS成長率
| Pharmaceuticals 収益成長 | 21.6% |
| 収益成長率 | 4.1% |
| 将来の株主資本利益率 | 18.6% |
| アナリストカバレッジ | Low |
| 最終更新日 | 15 Nov 2024 |
今後の成長に関する最新情報
Recent updates
Here's Why Dermapharm Holding (ETR:DMP) Has A Meaningful Debt Burden
Sep 28
Dermapharm Holding SE Beat Revenue Forecasts By 6.7%: Here's What Analysts Are Forecasting Next
Aug 31Dermapharm Holding SE's (ETR:DMP) P/E Still Appears To Be Reasonable
Aug 17It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope
Jun 21These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | 1,281 | 140 | 168 | 228 | 4 |
| 12/31/2025 | 1,221 | 130 | 156 | 214 | 5 |
| 12/31/2024 | 1,171 | 108 | 163 | 209 | 5 |
| 9/30/2024 | 1,174 | 91 | 157 | 197 | N/A |
| 6/30/2024 | 1,147 | 83 | 146 | 187 | N/A |
| 3/31/2024 | 1,129 | 57 | 137 | 179 | N/A |
| 12/31/2023 | 1,151 | 62 | 178 | 219 | N/A |
| 9/30/2023 | 1,172 | 95 | 240 | 279 | N/A |
| 6/30/2023 | 1,151 | 123 | 267 | 304 | N/A |
| 3/31/2023 | 1,128 | 146 | 287 | 323 | N/A |
| 12/31/2022 | 1,041 | 134 | 250 | 289 | N/A |
| 9/30/2022 | 1,024 | 176 | 222 | 269 | N/A |
| 6/30/2022 | 1,004 | 185 | 191 | 249 | N/A |
| 3/31/2022 | 980 | 211 | 190 | 252 | N/A |
| 12/31/2021 | 960 | 210 | 189 | 250 | N/A |
| 9/30/2021 | 902 | 162 | 153 | 209 | N/A |
| 6/30/2021 | 858 | 123 | 115 | 164 | N/A |
| 3/31/2021 | 828 | 95 | 96 | 139 | N/A |
| 12/31/2020 | 808 | 86 | 90 | 131 | N/A |
| 9/30/2020 | 775 | 80 | 60 | 104 | N/A |
| 6/30/2020 | 760 | 77 | 58 | 97 | N/A |
| 3/31/2020 | 743 | 85 | 69 | 114 | N/A |
| 12/31/2019 | 714 | 77 | 54 | 101 | N/A |
| 9/30/2019 | 674 | 73 | 51 | 90 | N/A |
| 6/30/2019 | 639 | 77 | 70 | 109 | N/A |
| 3/31/2019 | 611 | 73 | 84 | 115 | N/A |
| 12/31/2018 | 584 | 75 | 133 | 159 | N/A |
| 9/30/2018 | 558 | 75 | 143 | 165 | N/A |
| 6/30/2018 | 525 | 76 | N/A | 137 | N/A |
| 3/31/2018 | 498 | 79 | N/A | 120 | N/A |
| 12/31/2017 | 480 | 78 | N/A | 87 | N/A |
| 9/30/2017 | 486 | 84 | N/A | 84 | N/A |
| 12/31/2016 | 455 | 77 | N/A | 77 | N/A |
| 12/31/2015 | 396 | 13 | N/A | 40 | N/A |
| 12/31/2014 | 402 | 0 | N/A | 54 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: DMPの予測収益成長率 (年間18.1% ) は 貯蓄率 ( 1% ) を上回っています。
収益対市場: DMPの収益 ( 18.1% ) German市場 ( 21.1% ) よりも低い成長が予測されています。
高成長収益: DMPの収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: DMPの収益 ( 4.1% ) German市場 ( 5.6% ) よりも低い成長が予測されています。
高い収益成長: DMPの収益 ( 4.1% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: DMPの 自己資本利益率 は、3年後には低くなると予測されています ( 18.6 %)。